Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Revenue by Segment

Period Ending	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Operating	43.42M	64.51M	59.82M	58.49M	64.60M	48.62M	45.23M	43.88M
Operating Growth	-32.80%	32.69%	32.24%	33.30%	37.66%	-2.52%	-2.76%	10.57%
Grant	274.00K	95.00K	278.00K	618.00K	-	1.01M	1.00M	699.11K	453.11K		-	-
Grant Growth	-72.98%	-90.52%	-60.23%	36.39%	-	1,707.26%	1,037.25%	473.04%	202.07%		-	-

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.